Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Open Forum Infectious Diseases|July 2, 2025
Insights to a Cure: Unique Controller Phenotypes in the Rotterdam HIV-2 CohortKathryn S Hensley, Rob A Gruters, Els van Nood, et al.
Nature Medicine|June 23, 2009
HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferationNicolas Chomont, Mohamed El-Far, Petronela Ancuta, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2013
Cutting edge: Prolonged exposure to HIV reinforces a poised epigenetic program for PD-1 expression in virus-specific CD8 T cellsBen Youngblood, Alessandra Noto, Filippos Porichis, et al.
Ebiomedicine|August 1, 2026
HIV-1 reservoir inducibility and immune phenotypes after prolonged analytical treatment interruption: a long-term follow-up studyCynthia Lungu, Tanvir Hossain, Raquel Crespo, et al.
Nature Communications|May 1, 2021
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoirShringar Rao, Cynthia Lungu, Raquel Crespo, et al.
The Journal of Clinical Investigation|September 20, 2011
Loss of memory B cells during chronic HIV infection is driven by Foxo3a- and TRAIL-mediated apoptosisJulien van Grevenynghe, Rafael A Cubas, Alessandra Noto, et al.
Nature Medicine|March 4, 2008
Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infectionJulien van Grevenynghe, Francesco A Procopio, Zhong He, et al.
The Journal of Infectious Diseases|April 5, 2018
The S230R Integrase Substitution Associated With Virus Load Rebound During Dolutegravir Monotherapy Confers Low-Level Resistance to Integrase Strand-Transfer InhibitorsHanh T Pham, Lydia Labrie, Ingeborg E A Wijting, et al.
The Journal of Antimicrobial Chemotherapy|February 4, 2026
Cooperation between HIV-1 integrase natural polymorphism K156N and 3'PPT mutations in dolutegravir monotherapy failureJolieke A T van Osch, Jolanda J C Voermans, Haajar Ouzerne, et al.
Journal of Global Antimicrobial Resistance|November 8, 2022
HIV-1 resistance against dolutegravir fluctuates rapidly alongside erratic treatment adherence: a case reportJeroen J A van Kampen, Hanh Thi Pham, Sunbin Yoo, et al.
Pageof 4